Concerns about consensus guidelines for QTc interval screening in methadone treatment [2]

Annals of Internal Medicine

Volumn 151, Issue 3, 2009, Pages 216-217

  Cohen, Steven P ^a   Mao, Jianren ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHADONE; OPIATE; OXYCODONE; NARCOTIC AGENT;

CARDIOLOGIST; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; ELECTROCARDIOGRAM; EMERGENCY WARD; HEART ARRHYTHMIA; HUMAN; LETTER; OUTCOME ASSESSMENT; PATIENT EDUCATION; PATIENT SAFETY; PRACTICE GUIDELINE; PRIORITY JOURNAL; QT INTERVAL; QT PROLONGATION; RISK ASSESSMENT; TREATMENT DURATION; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; ELECTROCARDIOGRAPHY; HEROIN DEPENDENCE; NOTE; PATHOPHYSIOLOGY; STANDARD; TORSADE DES POINTES;

ELECTROCARDIOGRAPHY; HEROIN DEPENDENCE; HUMANS; METHADONE; NARCOTICS; PRACTICE GUIDELINES AS TOPIC; TORSADES DE POINTES;

EID: 68249093597     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-151-3-200908040-00014     Document Type: Letter

References (5)

1. Krantz MJ, Martin J, Stimmel B, Mehta D, Haigney MC. QTc interval screening in methadone treatment. Ann Intern Med. 2009;150:387-95. [PMID: 19153406]
2. Weschules DJ, Bain KT. A systematic review of opioid conversion ratios used with methadone for the treatment of pain. Pain Med. 2008;9:595-612. [PMID: 18565004]
3. Chugh SS, Socoteanu C, Reinier K, Waltz J, Jui J, Gunson K. A community-based evaluation of sudden death associated with therapeutic levels of methadone. Am J Med. 2008;121:66-71. [PMID: 18187075]
4. Krantz MJ, Lewkowiez L, Hays H, Woodroffe MA, Robertson AD, Mehler PS. Torsade de pointes associated with very-high-dose methadone. Ann Intern Med. 2002; 137:501-4. [PMID: 12230351]
5. Fanoe S, Jensen GB, Sjøgren P, Korsgaard MP, Grunnet M. Oxycodone is associated with dose-dependent QTc prolongation in patients and low-affinity inhibiting of hERG activity in vitro. Br J Clin Pharmacol. 2009;67:172-9. [PMID: 19159406]